Sleep Medicine
Volume 4, Issue 4 , Pages 339-342 , July 2003

Excessive daytime sleepiness in Parkinson's disease as assessed by Epworth Sleepiness Scale (ESS)

Received 22 February 2002 ,Revised 20 November 2002 ,Accepted 21 November 2002.

References 

  1. Tandberg E, Larsen JP, Karlsen K. Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community based study. Mov Disord. 1999;14(6):922–927
  2. Factor SA, McAlerny T, Sanches Ramos JR, et al.  Sleep disorders and sleep effect in Parkinson's disease. Mov Disord. 1990;5:280–285
  3. Van Hilten JJ, Weggeman M, Van der Welde EA, Kerkhof GA, et al. Sleep, excessive daytime sleepiness and fatigue in Parkinson's disease. J Neural Transm 1993; 5:235–244.
  4. Partinen M. Sleep disorders related to Parkinson's disease. J Neurol Sci. 1997;244:S3–S6
  5. Frucht SJ, Greene P, Fahn S. Sleep episodes in Parkinson's disease—A wake up call. Mov Disord. 2001;54:601–603
  6. Rye DB, Bliwise DI, Dihenia B, et al.  Daytime sleepiness in PD. J Sleep Res. 2000;9:63–69
  7. Johns MW. A new method of measuring daytime sleepiness. The Epworth sleepiness scale. Sleep. 1991;14:540–545
  8. Johns MW. Sleepiness in different situations measured by Epworth sleepiness scale. Sleep. 1994;17:703–710
  9. Johns MW. Rethinking the assessment of sleepiness. Sleep Med Rev. 1998;2:3–15
  10. Johns MW. Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the Epworth sleepiness scale: Failure of MSLT as a gold standard. J Sleep Res. 2000;(9):5–11
  11. Larsen JP, Dupout PE, Tandberg E. The clinical diagnosis of Parkinson's disease: proposal of diagnostic sub-group classified at different levels of confidence. Arch Neurol Scand. 1994;84:242–251
  12. Hughes AJ, Daniel SE, Blankson S, Lees AJ. A clinicopathological study of 100 cases of Parkinson's disease. Arch Neurol 1993;50:140–148.
  13. Rajput AH, Rozdilslay B, Rajput A. Accuracy of clinical diagnosis in Parkinsonism—a prospective study. Can J Neurol Sci. 1991;18:275–278
  14. Fahn S, Elton RT and members of the UPDRS development committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, Lieberman A, editors. Recent development in Parkinson's disease. Floham Park, NJ: Macmillan Health Care Information, 1987:133–163.
  15. Hoehn MH, Yahr MD. Parkinsonism onset, progression and mortality. Neurology. 1967;17:427–442
  16. Schwab RS, England AC. Projection technique for evaluating surgery in Parkinson's disease. In:  Gillingham FS,  Donaldson IML editor. Third symposium on Parkinson's disease. Edinburgh: Livingstone; 1969;
  17. WHO . ICD 10. Classification of mental and behavioural disorders: Clinical description and diagnostic guidelines. WHO; 1992;
  18. Hamilton M. Rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56–62
  19. American Psychiatric Association . Diagnostic and statistical Manual of mental disorders. 4th ed.. Washington DC: American Psychiatric Association; 1994;
  20. Kump K, Whalen C, Tishler PV, et al.  Assessment of the validity and utility of a sleep symptom Questionnaire. Am J Respir Crit Care Med. 1994;150:735–741
  21. Sauter C, Asenbaum S, Popovic R, Bauer H, et al. Excessive daytime sleepiness in patients suffering from different levels of obstructive sleep apnea syndrome. J Sleep Res 2000:9;293–301.22.
  22. Hobson DE, Lang AE, Martin WRW, et al.  Excessive daytime sleepiness and sudden-onset of sleep in Parkinson's disease. J Am Med Assoc. 2002;287(4):455–463
  23. Nausieda PA, Weiner WS, Kaplan LR, Weber S, Kluwans HL. Sleep disruption in the course of chronic levodopa therapy an early feature of levodopa psychosis. Clin Neurol Pharmacol ; (. 1982;5(Suppl. 2):183–194
  24. Marsden CD, Parkes JD, Research progress in Parkinson's disease. London: Pitman Medical, 1981:265 – 274 (Progress in neurological series, vol. 117).
  25. Critchley PHS, Malcom GP, Malcom PN, Gibb WR, et al.  Fatigue and melatonin in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1991;54:91–92
  26. Nauseida PA. Sleep disorders. In:  Koller WC editors. Handbook of Parkinson's disease. New York, NY: Marcel Dekker, Inc; 1987;p. 371–380
  27. Jellinger K. Pathology of Parkinson's disease. Changes other than the nigrostriatal pathways. Mol Chem Neuropathol. 1991;14:153–197
  28. Langston JW, Forno LS. The hypothalamus in Parkinson's disease. Ann Neurol. 1978;(3):129–133
  29. O'Suilleabhain PE, Dewey RB. Contributions of dopaminergic drugs and disease severity to daytime sleepiness in Parkinson disease. Arch Neurol. 2002;59(6):986–989
  30. Frucht S, Rogers J, Greene P, Gorden M, Fahn S. Falling asleep at the wheel; motor vehicle mishaps in person taking pramipexole and ropinrole. Neurology. 1999;52(52):1908–1910
  31. Olanow CW, Schapira AHV, Roth T. Editorial. Neurology. 2000;54(1):274
  32. In:  Kryger MH,  Roth T,  Dement WC editor. Principles and practice of sleep medicine. 2nd ed.. Philadelphia: WB Saunders; 1994;
  33. Schafer D, Greulich W. Effects of Parkinsonian medication on sleep. J Neurol :(2000;247(Suppl. 4):IV/24–IV/27.
  34. Ryan M, Slevin JT, Wells A. Non ergot dopamine Agonist induced sleep attacks. Pharmacol Ther. 2000;(20(6):724–726
  35. Benbadis SR, Mascha E, Perry MC, et al.  Association between the Epworth Sleepiness scale and the multiple sleep latency test in a clinical population. Ann Intern Med. 1999;130(4):289–292

PII: S1389-9457(03)00105-9

doi: 10.1016/S1389-9457(03)00105-9

Sleep Medicine
Volume 4, Issue 4 , Pages 339-342 , July 2003

Article Tools